Inactive Instrument

Biondvax Pharmaceuticals Ltd Share Price Other OTC

Stocks

16/07/19	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
08/07/19	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
26/06/19	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
18/06/19	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
10/06/19	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	01/03/2021
Uri Ben-Or DFI	Director of Finance/CFO	55	31/12/2006
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	31/12/2021

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	29/09/2019
Samuel Moed BRD	Director/Board Member	64	23/03/2020
Adi Raviv BRD	Director/Board Member	71	23/03/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIONDVAX PHARMACEUTICALS LTD	-.--%	-.--%	-	-	38.98M
LONZA GROUP AG	-1.52%	-3.09%	-2.00%	+13.48%	48.93B
REVOLUTION MEDICINES, INC.	-0.40%	+1.03%	+418.57%	+527.30%	45.01B
IQVIA HOLDINGS INC.	-1.42%	+2.30%	+42.67%	+22.37%	44.07B
BEONE MEDICINES AG	-1.22%	-2.31%	+4.82%	+77.49%	40.73B
CELLTRION, INC.	+0.53%	-1.36%	+16.87%	+46.82%	33.52B
ASCENDIS PHARMA A/S	-0.21%	+9.14%	-	-	17.77B
MEDPACE HOLDINGS, INC.	-0.35%	-1.56%	+21.42%	+120.75%	16.5B
EUROFINS SCIENTIFIC SE	-1.65%	-1.41%	+11.89%	+30.99%	14.67B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.65%	-1.03%	+75.93%	+41.12%	13.77B
Average	-0.79%	+0.53%	+73.77%	+110.04%	30.55B
Weighted average by Cap.	-0.88%	+0.11%	+89.26%	+128.77%